Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr;9(2):284–294. doi: 10.21037/tau.2020.02.18

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2020 Translational Andrology and Urology. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

The diagnostic value of urinary ATP to distinguish between BPH patients and normal people. (A) Comparison of urinary ATP concentration between BPH patients and asymptomatic controls. There was a significant difference between the two groups (***, P<0.001). (B) ROC curves of urinary ATP concentration. ATP (black line) and the results corrected for urinary creatinine levels (ATP/Cr, grey line) were plotted as continuous variables to distinguish between true-positive and false-positive rates among BPH patients and controls. AUC was 0.83 for ATP and 0.82 for ATP/Cr, and both results were significant (P<0.001). There were no differences (P>0.05) between the two variables (ATP vs. ATP/Cr).